BiPAP Use in DNI Patients

Core Rationale for BiPAP in DNI Patients

The European Respiratory Society states that contraindications to NIV can be overridden when a decision has been made not to proceed to invasive ventilation, directly addressing the DNI scenario 2
BiPAP serves as the primary respiratory support modality when invasive mechanical ventilation is not an option due to patient preferences or goals of care, and can be used in DNI patients even when some relative contraindications exist, as long as contingency plans acknowledge that intubation will not occur if BiPAP fails 2

The American Thoracic Society implies that BiPAP reduces intubation rates and mortality in hypercapnic respiratory failure, making it ideal for DNI patients with COPD exacerbations with respiratory acidosis 1, 3
BiPAP is specifically indicated for neuromuscular disease with acute-on-chronic respiratory failure, such as chest wall deformity or neuromuscular conditions causing hypercapnic failure, as per the American Academy of Neurology 4, 1
The European Society of Cardiology suggests that both BiPAP and CPAP decrease mortality and intubation rates in cardiogenic pulmonary edema, with BiPAP reserved for cases where CPAP fails or respiratory acidosis develops 1

The American College of Chest Physicians states that BiPAP should not be used in DNI patients with recent facial or upper airway surgery, facial burns or trauma, fixed upper airway obstruction, active vomiting, inability to protect the airway, life-threatening hypoxemia unresponsive to high FiO2, or apnea or impending respiratory arrest 1, 2, 3, 4

The American Thoracic Society recommends that BiPAP should be discontinued during active bleeding in massive hemoptysis, with a consensus rating of 8/10 5
The British Thoracic Society suggests that BiPAP should be discontinued until chest tube placement in most cases of pneumothorax, though it can be used cautiously with a drain in place 5, 2

The Society of Critical Care Medicine implies that DNI patients on BiPAP with persistent dyspnea, hemodynamic instability, or pH <7.25 should still be managed in ICU/HDU settings for optimal monitoring and symptom management, even though intubation is not planned 6
The American Academy of Hospice and Palliative Medicine recommends that when BiPAP clearly fails, transition to comfort-focused care with opioids and anxiolytics is appropriate 6